Consortium Aims to Standardize IHC Biomarker Tests for Precision Medicine, Starting With HER2
The Consortium for Analytic Standardization hopes to bring an archaic technology into the 21st century by producing calibrated standards for the most utilized IHC-based biomarker tests.
Source: precisiononcologynews.com